TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: American Orthopedic Foot and Ankle Society Score (AOFAS) - Change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SF-36v2 Health Survey (SF-36v2) - Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Laitinen Pain Indicator Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: hSBA GMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hSBA proportions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute myocardial blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in worry and rumination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of Time in the Therapeutic Range of INR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Systemic Pro-inflammatory Cytokine Levels (IL-6, IL-1ra, CRP, sTNFαRII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Salivary Diurnal Cortisol Slope and Daily Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: One Year Event-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Fall frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Insomnia Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: COPD admission rates
Endpoint domain: Mortality/survival
Primary endpoint: % Change in flux of blood after skin heating to 44 C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Numeric Rating Scale for Pain (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of teeth with fractured restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Percentage of adequate anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction of alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Lyme disease
Endpoint domain: Mortality/survival
Primary endpoint: Area under the curve of glucose and insulin postprandial responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in Ashworth Scale (AS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator's Global Impression of Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interval between induction and delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Patellar thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monopodal Postural Sway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weaning success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral Blood Treg Percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number diagnosed and treated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CD4+ cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in peripheral blood lymphocyte activation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ease of Use in Advancing Measuring Device Catheter
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of Extending and Retracting the Device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of Use in Placing the Measuring Device Adjacent to the Polyp
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of Use in Taking a Picture for Photo-documentation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of constipation recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Failure of maintaining normal bowel movements without PEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Drug Elimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capabilities at week 24
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Social capabilities at week 24
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Psycho-affective capabilities at week 24
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral capabilities at week 24
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Acute Mountain Sickness
Endpoint domain: Adverse events/effects
Primary endpoint: Change in liver glycogen concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute Change in Inflammatory Lesion Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain measurement at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain measurement during internal rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adenosine related adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Progression Free Survival at six months
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of COVID-19 positive cases
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of maximum tumor size measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SOURCE observational scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Throughput
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relapse of infective endocarditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: occurrence of embolic event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Response of chronic hand dermatitis to study treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Area Under the Curve (AUC) from Time Zero to Extrapolated Infinite Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk stratification of patients with CLL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary collateral function (CFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urine output in the first hour post unclamping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VO2peak (peak oxygen uptake)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic availability of methionine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: platelet reactivity measured in P2Y12 reaction units (PRU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Microbiologically confirmed COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Flow mediated Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Enrollment rate among participants approached
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention rate among participants enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participation in Facebook group
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Incidence rate of changed surgical plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median radiographic progression free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic accuracy of HER2 imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Metabolic signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Hyporesponsiveness to EPO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score on the Positive and Negative Symptom Scale (PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Scale of Suicidal Ideation (MSSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Columbia-Suicide Severity Rating Scale (CSSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acoustic changes in vowel production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant pocket hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events (AEs) and Treatment Emergent Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Latency to Persistent Sleep (LPS) Assessed Using Polysomnography (PSG) Measurement at Day 1
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change From Baseline in Total Sleep Time (TST) Assessed Using PSG at Day 1
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Joint position sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: percent of inhibition of ADP-induced platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ventilator-free Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean Trough Sitting Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: free-wall RV longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progress-free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Actigraphy-measured sleep onset latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Actigraphy-measured sleep efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Actigraphy-measured total sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Accelerometer Vector Magnitude Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of residual bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Visual Analogue Scale Score Referring to Radicular Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Pain Score (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of primary graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3 or 4 aGVHD
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With HIV Viral Suppression (Missing Imputed as Unsuppressed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With HIV Viral Suppression (Complete Case)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With HIV Viral Suppression (Per-protocol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Unilateral Uncorrected Near Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: midazolam Area Under the Curve from time 0 to last quantifiable concentration (AUClast) in Period 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: midazolam Cmax on Day 1 in Period 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: midazolam Area Under the Curve from time 0 to infinite (AUCinf) in Period 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly Rate of Spontaneous Bowel Movements at 4 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Weekly Rate of Complete Spontaneous Bowel Movements at 4 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety of OMS643762
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative Pulmonary Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Recurrence-free survival or malignant transformation-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in LOH status (positive to negative) of OPL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Were Assessed As Seizure Free
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood Brain Barrier leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (0-inf) of Nintedanib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Nintedanib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All Cause-death
Endpoint domain: Mortality/survival
Primary endpoint: Invasive Mechanical Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tear Lake Evaluation at 7 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear Lake Evaluation at 28 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of time spent in at least moderate physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragm function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical Outcome related to RAAS genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Outcome related to Adrenergic receptors genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical Outcome related to Cardiac Fibrosis genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 24-h Sedentary Energy Expenditure from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in 24-h Sleeping Energy Expenditure from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of diagnostic tests during gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological clearance of treated isSCC lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Endothelial Function (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular interactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CAARS DSM-IV ADHD Symptoms Total
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAARS Inattention/Memory Problems indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glucose level measured by HbA1C level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Achieving PASI75 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Peak plasma concentration (Cmax) of tenofovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC) of tenofovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the plasma Concentration versus time curve (AUClast) of Bepotastine Besilate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Bepotastine Besilate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in the pre-patent period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Difference in the total number of malaria events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Patients With Chronic Myeloid Leukemia (CML) Who Develop Molecular Recurrence After Discontinuing TKIs
Endpoint domain: Mortality/survival
Primary endpoint: Patient-reported Health Status Related to Fatigue of Patients at 6 Months
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Patient-reported Health Status Related to Diarrhea of Patients at 6 Months
Endpoint domain: Life impact
Primary endpoint: survival at 9 months
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants Who Relapsed by Week 4 Postpartum
Endpoint domain: Mortality/survival
Primary endpoint: Individual component survivorship
Endpoint domain: Mortality/survival
Primary endpoint: Symptoms of Post-Traumatic Stress Disorder (PTSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal mortality rate (NMR)
Endpoint domain: Mortality/survival
Primary endpoint: Effect size of the exercise intervention on physical function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAQ Disability Index (HAQ-DI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Toxicity associated with TAB014 treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Reporting at Least One Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Reporting Adverse Events Leading to Withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration versus time curve from zero to infinity divided by dose of total BAY1753011 in plasma after single dose administration (AUC/D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed drug concentration divided by dose of total BAY1753011 in plasma after single dose administration (Cmax/D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration versus time curve from zero to infinity divided by dose of unbound BAY1753011 in plasma after single dose administration (AUCu/D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed drug concentration divided by dose of unbound BAY1753011 in plasma after single dose administration (Cmax,u/D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Virologic Response (SVR) < Lower Limit of Quantification (LLOQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Permanent discontinuation of study drug due to adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Initial comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: changes in urinary excretion of citrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Refracture rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm Delivery or Fetal Death
Endpoint domain: Mortality/survival
Primary endpoint: Decrease length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence of adverse events related to Convalescent Plasma transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Airtightness evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: One-year overall survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Blood glucose fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Brain Activity During Task (Task-based fMRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Brain Connectivity During Rest (Resting-state fMRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual Analog Scale Appetite Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appetite Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes